Compare SNAP-8 and Argireline-type cosmetic peptides by identity, evidence, concentration basis and serum formulation. Written for cosmetic brands, formulators, distributors and professional B2B buyers.
The practical difference
SNAP-8 is a trade name associated with Acetyl Octapeptide-3, while Argireline is associated with Acetyl Hexapeptide-8. They are different peptide sequences and commercial materials. Neither name tells a buyer the supplied concentration, solvent, preservative or recommended dose, so a reliable comparison begins with technical files.
Why consumers compare them
Both ingredients appear in products positioned for the appearance of expression lines, including forehead and eye-area lines. Online content often describes them as topical alternatives to injectable neuromodulators. That comparison can mislead users and create regulatory risk: cosmetic serums act in a different context and should be supported with cosmetic appearance claims.
Concentration basis
A formulation might use a stated percentage of an Acetyl Octapeptide-3 or Acetyl Hexapeptide-8 stock solution. That is not necessarily the percentage of pure peptide. Request the active concentration of the supplied grade and express internal cost and dose calculations on a consistent basis.
Evidence comparison
Published studies can involve one peptide, a multi-ingredient formula or a delivery system such as a microneedle patch. Results from those systems should not be transferred directly to a conventional serum. Compare study vehicle, dose, population, duration, control and endpoint before ranking ingredients.
Formulation questions
Confirm water solubility, pH window, temperature limit, carrier, preservative and storage for each candidate. Evaluate viscosity and microbiological protection after adding the stock solution. If both peptides are combined, the formula still needs a clear rationale, stability data and truthful claims.
Which should a brand select?
Choose the grade whose documented composition, evidence, cost-in-use and supplier support fit the brief. Acetyl Hexapeptide-8 has strong consumer name recognition; Acetyl Octapeptide-3 may provide differentiation. A controlled single-peptide formula may be easier to substantiate than a complex blend, while a blend can support broader positioning when technically justified.
RFQ and scale-up
State the exact INCI, product code, active basis, target formula dose, base, pH, packaging and claim plan. Approve a representative lab sample, then verify the pilot matches appearance, pH, viscosity and microbiological specifications before releasing commercial artwork.
Selected research for further reading
These sources provide background and do not substitute for finished-product substantiation.
Need a product-specific specification?
Send the peptide, format, quantity, packaging and destination market. We will confirm composition, MOQ, documents and sample options.
Ask the B2B TeamPublished August 9, 2026. Educational B2B content; not medical advice.